Strategic Partnerships Fortis Life Sciences collaborates with diagnostics and life sciences companies and maintains multiple in-house brands, indicating demand for collaboration on end-to-end solutions and potential cross-sell of reagents, validated kits, and manufacturing capabilities.

Global Expansion With offices across North America and an Asia-Pacific presence including Seoul, there are opportunities to sell regional manufacturing, distribution, and regulatory support services to global clients expanding manufacturing or R&D footprints.

Scale and Capabilities Fortis offers end-to-end capabilities from design to GMP and ISO 13485 compliant manufacturing, suggesting potential to upsell large-scale contract development and manufacturing, including reagent supply and custom solution validation.

Innovative Offerings Recent launches such as LFA kits with Au nanoparticles and collaborations in spatial biology indicate receptiveness to advanced diagnostics and novel assay formats, presenting opportunities to propose next-gen testing platforms and superior sensitivity solutions.

Funding and Wins Grants and partnerships (e.g., AbNano VHH Discovery grant to Deliver Biosciences) reflect active R&D funding and collaboration potential; target similar grant-aligned programs and joint development opportunities with prospective customers.